Testing care plans for single-heart (univentricular) defects
Part of Genetic & congenital, Heart & circulation clinical trials.
This study follows people with a single-ventricle (univentricular) heart defect who need a multi-step treatment leading to the Fontan procedure. It aims to better understand how this staged care should be delivered and monitored over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a single-ventricle (univentricular) congenital heart defect
- Your cardiology team expects you will need a multi-stage treatment
- You need treatment that includes the Fontan procedure
- There are no listed exclusion criteria for the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people born with a single-ventricle heart condition who now live with a Fontan circulation. It mainly focuses on having a dedicated clinic visit (“Fontan clinic session”) and checking how that care works for you.
This study follows children with a rare heart condition (univentricular heart) who need multiple surgeries, including a procedure called Fontan. Researchers want to understand how different blood-flow patterns after surgery affect long-term health and outcomes.
This study follows patients who received an AFR device (a special catheter-based implant) to help improve blood flow in their heart after a Fontan surgery. Researchers want to understand how well the device works and its safety over time.
This trial tests a coordinated treatment plan for newborns with critical congenital heart disease, starting before birth and continuing after delivery. It aims to improve outcomes for babies who need two-ventricle repair surgery.
This study uses routine heart scans (either echocardiogram or MRI) to better understand single-ventricle heart conditions. It may help improve how doctors evaluate and monitor your heart over time.
This trial tests whether an infusion of heart stem/progenitor cells can improve outcomes for children with a single working heart chamber (single ventricle) who are scheduled for the next surgical stage (Glenn or Fontan). It may help the heart function after surgery, but participation depends on several heart, lung, brain, and overall health safety criteria.
Hear when a new Univentricular Heart trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.